He declined to predict when the drug might reach the market, noting that the studies should take a year.

Suddenly the drug reached his brain and he slumped limp.

Third, the absence of patents would continue to keep prices low once drugs reached the market.

That does not mean the drug is reaching a lot of patients in Hungary.

In seconds the drug would reach his brain and put him out.

That could mean the drug, Vevesca, would reach the market in 2002.

Over two decades starting in 1986, the drug reached over 55 million people.

The drug will not reach the market for at least a year.

The drugs, experts say, have now reached a turning point where benefits must be balanced by side effects and cost.

He said the drug might reach sales of $500 million by 2000.